Iron Deficiency Anemia






Total Body Iron Stores
- Male: 50 mg/kg
- Female: 40 mg/kg
Mineral Iron
Sources

- Heme:
- Animal source (20 - 40% bioavailability).
- Non-Heme:
- Plant source (6 - 9% bioavailability):
- Pumpkin seeds (Rich).
- Pista.
- Dates.
- Green leafy vegetables.
- Poor manās source: Jaggery
- Note:Ā Iron in jaggery due to iron vessel used for production.
- Pregnancy:
- Iron cannot be fully supplemented by diet alone
- Supplementation required regardless of Hb or socioeconomic status
- Mass prophylaxis:
- Use Tablet ferrous sulphate
- (Us Ate)
- Withhold in:
- Acute illness (fever, pneumonia, diarrhea)
- Known thalassemia major
- History of repeated blood transfusion
- Always continue iron for 3 months after Hb normalizes
- To replenish iron stores
WHO Anemia Definition (Hemoglobin Levels):
- Best for epidemiological surveys
- Insensitive for early nutrient depletion
- Levels:
- Healthy Adult Male: <13 g/dL
- Healthy Adult Female: <12 g/dL
- Pregnant Woman: <11 g/dL
- CKD Patient: <10 g/dL
- Children 6 monthsā5 years: Hb <11 g/dl
- Children 6-14 years: Hb <12 g/dl
Causes
- Dietary, blood loss (trauma, PUD, colon cancer, menorrhagia)
- Hookworm infection
Approach to anemia in children:

Iron Deficiency Anemia
- Most common cause of nutritional disorders in the world
- Most common cause of anemia in the world
- Vitamin C helps in the absorption of iron
- Associated with celiac disease
Iron Metabolism (for IDA):

- Absorption:Ā Duodenum.
- Dietary Fe3+ āĀ Fe2+Ā (by Cytochrome B Reductase) for absorption.
- Fe2+ into duodenal cells viaĀ DMT1 (Divalent Metal Transporter).
- Fe2+ āĀ Fe3+Ā (by Hephaestin and Ceruloplasmin) inside cell.
- Fe3+ out of duodenal cells viaĀ Ferroportin.
- Transport:Ā Transferrin bound Fe3+ (Normal Saturation: 33%).
- Storage:Ā Ferritin.
- Regulated by Hepcidin.
Absorption
- Ferric iron (Ingested) ā Ferrous iron (Absorbed).
- FerrUs ā comes to us
- Activated by: Vitamin C
- Inhibited by: Phytates, tannin, oxalates, fiber, calcium.
Mnemonic:
- "I'm Iron. My religion wasĀ 3."
- This refers toĀ Fe³āŗĀ
- "I need to go to a country, but I can only do so by crossing another country which told me 'Do CHange' your religion."
- Do CHangeĀ āĀ Duodenal Cytochrome BĀ (DuodenalĀ Cyto B)
- Duodenal Cytochrome BĀ reducesĀ Fe³⺠to Fe²āŗ.
- I gave into 'demandā
- demandĀ āĀ DMT1Ā (DivalentĀ MetalĀ Transporter 1)
- DMT1 transports the non-hemeĀ Fe²āŗĀ (ferrous iron) into the enterocyte.
- "I changed to religionĀ 2Ā and entered."
- This representsĀ Fe²āŗĀ (ferrous iron), the form that enters the cell via DMT1.
- "And then escaped by aĀ ferri."
- ferriĀ āĀ Ferroportin 1
- Ferroportin 1 transports ironĀ outĀ of the enterocyte, across the basolateral membrane.
- āSid tried to kill me when I was on Ferri
- Hepcidin inhibits Ferroportin
- "Hamza/HafsaĀ helped me change my religion back toĀ 3."
- Hamza/HafsaĀ āĀ Hephaestin
- HephaestinĀ oxidizesĀ Fe²⺠back toĀ Fe³āŗĀ at the basolateral membrane, before it enters circulation.
Disorders
Disorder | Features | Diagnosis | Treatment |
IDA | Microcytic hypochromic anemia | ā Ferritin (1st), āTIBC | Oral iron + Vit C; Vit E for radicals |
Hemochromatosis | Liver damage, DM, Skin pigmentation | HFE mutation | Phlebotomy, Deferoxamine |
Iron Distribution in Body
Form | Percentage of Total Body Iron | Notes |
Hemoglobin | 65-67% | Iron deficiency affects Hb synthesis ā lagging cytoplasmic maturation. |
Storage Forms | 2-7% | ć
¤ |
- Ferritin | - | Most abundant storage form. |
- Hemosiderin | - | - |
Myoglobin | 3-5% | - |
Labile Pool | 2-2% | - |
Transport Iron (Transferrin-bound) | 0.08% | - |
Dietary Iron & Requirements
Category | Details |
Normal Diet Iron Content | 10-20 mg Fe |
Absorption Rate | ~10% absorbed, i.e., 1 mg |
Daily Iron Requirements | ć
¤ |
- Infants | 1 mg |
- Children | 0.5 mg |
- Adult Male | 1 mg |
- Adult Female (Non-Pregnant & Post-menopausal) | 2 mg |
- Pregnant Female | 3 mg |
Iron Regulation by IRPāIRE System

InvolvesĀ
- Iron Regulatory ProteinsĀ (IRPs)
- Iron-Responsive ElementsĀ (IREs)
- Transferrin receptor-1 iron responsive elements
When Iron Concentration is Low
- IRP binds 3' IRE of Tf
- r mRNA
- T ā Three
- stabilizes mRNA ā ā Tfr mRNA concentration
- ā ā Tfr
- IRP binds 5' IRE of ferritin mRNA
- Ferritin ā Five
- blocks translation ā No CHANGE in Ferritin mRNA / Apoferritin mRNA
- ā ā ferritin
When Iron Concentration is High
- IRP dissociates from 3' IRE of Tfr mRNA
- unstable mRNA ā ā Tfr synthesis.
- IRP dissociates from 5' IRE of ferritin mRNA
- translation allowed ā ā ferritin synthesis.
Clinical Features



- Tongue: Soreness
- Papillary atrophy ā Loss of filiform papillae.
- Mouth:Ā Angular Stomatitis.
- Hypopharynx: Dysphagia, Esophageal webs āĀ Plummer Vinson Syndrome.
- Stomach: Achlorhydria, Gastritis.
- Children:
- Hyperactivity syndromes.
- Impaired Growth & Development
- due to growth hormone related to transferrin levels
- High Output Cardiac Failure
- Neuropsychiatric manifestations.
- Nails: Koilonychia (Spoon shaped nail)
- Mild Splenomegaly
- Hair loss
Feature | Iron Deficiency Anemia (IDA) | Anemia of Chronic Disease (AOCD) | Sideroblastic Anemia |
Commonality/ Cause | Most common deficiency | Chronic diseases (e.g., RA) | Protoorphyrin missing; ⢠ALA synthase def. ⢠Vit B6 ⢠Alcohol intoxication, ⢠Lead poisoning |
Mechanism | Iron lack | Chronic inflammation ā IL-6 /Activin ā āā Hepcidin ā ā inhibition of ferroportin ā Iron from store site and absorption site cannot be released ā āFe absorption & āFe release | Iron present, but not incorporated into Hb |
Serum Iron 50-150 mcg/dL. | Low ⢠Better indicator of nutrient depletion ⢠<0.5 mg/L ā Indicates iron deficiency | Low | High |
Ferritin 30-300 ng/mL ⢠<10 mcg/L ā No stored iron Ferritin To Be Seen (TIBC) ā Ferritin oppositely corelates with TIBC | Low ⢠Earliest marker for Iron deficiency ⢠Most sensitive and definitive indicator ⢠Most commonly used ⢠Best in low-prevalence populations | High | High |
TIBC 300-360 µg/dL. ⢠Top ā I ⢠Bottom ā C, S | High | Low | Low |
Transferrin Saturation = (S.Fe / TIBC) x 100 ~33% (100/300 x 100). | Low Used clinically to assess iron status | Low | High |
RDW | Elevated | Normal/Elevated | Variable |
Peripheral Smear | Microcytic hypochromic,Ā anisocytosis,Ā poikilocytosis,Ā pencil cells | Normocytic normochromicĀ > microcytic hypochromic | Pappenheimer bodiesĀ (iron dots, Pearl stain) |
Bone Marrow | Pearl stain of BM aspirate Zero iron (most definitive, specific, not done routinely) | Increased iron stores | Ringed sideroblastsĀ - Pearl stain, - ā„5 granules - ā„1/3rd nucleus |
Clinical Sign (IDA) | Koilonychia (Spoon-shaped nails) | Features of underlying disease | Features of underlying cause |
Treatment | Iron supplements | Treat underlying chronic disease | Address cause, B6 supplementation |
Most Sensitive Test
- Serum Soluble Transferrin Receptor Assay
Earliest marker
- S. ferritin
Peripheral Smear Findings
- Prussian Blue staining: Shows absence of iron stores.
- MCV: Normal toĀ āĀ (low)
- MCH: Normal toĀ āĀ (low)
- MCHC: Unchanged (Normal 31-36 g/dL)
- Micronormoblastic Reaction and Basophilia.
D/D of Microcytic, Hypochromic Anemia

Mentzer Index

- Formula: (MCV / RBC count) x 100.
- Interpretation:
- <13: Thalassemia minor
- Mnemonic: Tha Lessemia ā < 13
- >13: Iron Deficiency Anemia
Bone Marrow Examination
- Initially Hypoproliferative.
- Followed by erythroid hyperplasia (due to ineffective erythropoiesis).
Anisopoikilocytosis & RDW
- Anisopoikilocytosis:
- Earliest change in IDA.
- Normal RDW: 8.5-12.5%.
- >12.5%: Anisopoikilocytosis.
DDs for Pallor and lethargy
Hepatosplenomegaly.
- Absent:
- No petechiae.
- Iron deficiency anemia.
- Pure red cell aplasia.
- Anemia of chronic disease.
- Petechiae Present:
- Aplastic anemia.
- Bleeding disease.
- Coagulation disease.
- DIC.
- Present:
- Lymphadenopathy Absent.
- Thalassemia.
- Sickle cell disease.
- Hereditary Spherocytosis.
- Lymphadenopathy Present.
- Acute Leukemia.
- Infection.
- Lymphoma.
Treatment
Iron Therapy
Oral Iron Therapy (First Line)
- Ferrous sulphate (200 mg):
- Contains 60 mg elemental iron ~10% absorption.
- Absorption increases to ~20% in deficiency.
- Only 6 mg absorbed from a normal dose.
- Ferrous Fumarate
- ferrous gluconate
- Side effect:Ā black stool
- Tabs or drops
- Drops ā deep in mouth
- As they cause skin pigmentation.
- Earliest response - Reticulocytosis.
- Adequate response ā Hb ā by 0.5 g/dl/week
- Factors affecting:
- Ascorbic acid : Increase Absorption
- Phytates, Tannate and oxalates : Decrease Absorption
- Iron deficiency anemia:
- Always continue iron for 3 months after Hb normalizes
- To replenish iron stores
Oral Iron Absorption Test
- Step 1: Measure baseline serum iron
- Step 2: Give 325 mg Ferrous SOā orally
- Step 3: Wait for 1 hour
- Step 4: Re-measure serum iron
- Interpretation
- ā„100 mg/dL rise ā Good oral absorption
Factors Influencing Iron Absorption:
- Enhancers:
- Acidic pH ā ā Iron absorption
- Ascorbic Acid (Vitamin C)
- Combine with Ferrous sulfate
- ā Fe³⺠to Fe²āŗ
- ā Solubility, ā absorption
- Inhibitors:
- Phytate
- Tannate
- Tea
IV Iron Therapy
Iron Deficit (mg) = 2.2 x Body Weight (kg) x (Target Hb - Actual Hb) + 1000
Parenteral Iron therapy
- Ferrous Sucrose (200 mg)
- Ferric Carboxy Maltose
- 1 gm single dose IV
- Iron Isomaltose
- 1 gm single dose IV
Other Preparations of injectable iron are:
- Iron Dextran ā Can be given IV as well as IM
- Mnemonic: Dextran ā dual route
- Iron Sorbital citrate (Used IM only)
- Mnemonic: Sorbitol ā Sirf IM
- IM iron is given by Z-tract technique to avoid pigmentation.
NEWER IRON PREPARATIONS:
- Ferumoxytol
- Ferric Carboxy Maltose (Injectafer)
- Sodium Ferric Gluconate
- Iron Sucrose
Blood transfusion:
- If Hb <7 g/L regardless of symptoms
- If Hb < 8 g/L + anemic symptoms
- If Hb < 9 g/L + heart disease
Anemia in Pregnancy
- M/c indirect cause of maternal mortality in India.
- Causes :
- Physiological Anemia
- Hb cut off is raised for defining anemia in pregnancy.
- M/c cause of anemia in pregnancy.
- Normocytic normochromal anemia.
- Hb :Ā Never falls below 11 g/dL.
- Pathological Anemia
- M/c cause :Ā Iron Deficiency Anemia (IDA).
- Microcytic hypochromic anemia.
- Hb :Ā <11 g/dL.
- WHO Classification : 7 - 10 - 11
- Mild :Ā 10-10.9 g/dL.
- Moderate :Ā 7-9.9 g/dL.
- Severe :Ā <7 g/dL.
- Best Screening test for anemia in Pregnancy
- S. ferritin > MCHC
Iron requirements
- Total iron requirement during pregnancy - 1000 mg
- Fetus and placenta -300 mg
- Rest for mother
- Fe - trimester wise
- 1st : 1-2 mg/day
- 2nd: 4-6 mg/day
- 3rd: 6-8 mg/day
- 2nd half of pregnancy : 6-8 mg/day
- Note :
- ICMR Very severe anemia :Ā Hb <4 g/dL.
- Thalassemia :Ā Rx with iron is C/I.
- Nestroft test.
- IDA :Ā Rx with iron supplementation.

ANEMIA MUKT BHARAT PROGRAM


- 6 x 6 x 6 Initiatives
Interventions :
- IFA pillĀ : Weekly
- Deworming : Albendazole for hookworm infection
- 200 mg (1/2 tab) for 1-2 yrs
- 400 mg (1 tab) for >2 yrs
- Biannually (Twice a year) :
- (National deworming days)
- 10th February &
- 10th August
- Not against ascariasis
- Delayed cord clampingĀ : Prevention of neonatal anemia
- Digital hemoglobinometer.
- Mandatory iron & folic acid fortified foods
- Non-nutritional causes of anemia

- Pregnant woman IFA
- From 4th month of pregnancy till 6 months post-delivery

Mnemonic
- Pink ā Primary kids (5ā9 yrs)
- Blue ā Boys & girls (Adolescents)
- Red ā Reproductive (Pregnant + Lactating)

Supplementation in Pregnancy
Situation | Recommendations | Notes |
WRA | ⢠IFA Pill given | ⢠Prevent anemia : 1 tablet/day ⢠Rx anemia : 2 tablets/day. |
First 12 weeks | ⢠IFA pill stopped Ⳡ(d/t risk of gastric irritation) ⢠Folic acid 400 mcg/day | RDA of FA in pregnancy : 500 mcg ⳠTo prevent neural tube defects |
After 12 weeks | ⢠IFA pill | 1 tablet/day for Ⳡat least 180 days in pregnancy |
Rx anemia | ⢠IFA pill given at time of diagnosis ⢠Irrespective of trimester | ć
¤ |
- Deworming:Ā Once in second trimester.
IFA Pill
- Red color pill.
- Fe :Ā 60 mg + Folic acid : 500 mcgĀ (To prevent megaloblastic anemia).
- Dose to
- Prevent anemia :Ā 1 tablet/dayĀ
- Rx anemia :Ā 2 tablets/day.
- Recommended after 12 weeks
- 1 tablet/day for at least 180 days in pregnancy
MANAGEMENT
Parenteral iron :
- C/I :Ā 1st trimester.
- Rate of Hb ā :Ā Ā 0.7 g/dL/week after 3rd week.
Dose :Ā Ganzoni formula.
- 2.4 x Pre-pregnancy weight x Hb deficit (target Hb - Patients Hb) + 500 mg
- Mnemonic Iron man te set Gansoni
- Note:
- Target Hb can be 11 or 14
- If target = 11
- Need maintenance till 180 days after delivery
- Oral Iron is given
- If target is 14
- Do not need maintenance
- Minimum time gap b/w oral & parenteral iron :Ā
- 3 weeksĀ (Oral iron tablets C/I with parenteral therapy).
Oral iron therapy :
- Rate of Hbā : Same as parenteral
- For loading as well as maintenance therapy
- If target Hb = 11 g/dL
- Maintenance dose :Ā
- 1 pill/day continued throughout pregnancy up to 180 days after delivery.
Treatment Algorithm :

Blood transfusion at any GA if
- Hb <5g%
- Signs of heart failure
1st trimester
- No parenteral iron therapy
- 2 IFA tab per day OR
- 60 mg elemental Fe + 0.5 mg FA
- Blood transfusion if
- Unstable vitals.
- Signs of heart failure
- Thalassemia.
- Hb <5 g/dL at any gestational age.
2nd and 3rd trimester
ć
¤ | Hb > 7g% | Hb - 5 - 6.9 g% | Hb < 5g% |
<34 weeks | Oral iron (2 tablets/day) ā³ Check Hb after 3 weeks/1 month ā³ Non-compliant ā shift to parenteral iron | Parenteral iron. | Blood transfusion |
ā„34 weeks | Parenteral iron | Blood transfusion. | Blood transfusion |
Special Considerations
- Thalassemia & Sickle Cell Disease:Ā
- Folic acid only
- Calcium Recommendation (Pregnant & Non-Pregnant Females):Ā
- 1000 mg